Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as XmAb412 Monoclonal Bispecific Antibody
XmAb412 · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Part A: Active Drug | ACTIVE_COMPARATOR | Active XmAb412 to be administered to healthy adult participants. |
| Part A: Placebo | PLACEBO_COMPARATOR | Placebo Comparator to be administered to healthy participants. |
| Part B: Active | ACTIVE_COMPARATOR | Active XmAb412 to be administered to healthy participants. |
| Part B: Placebo | PLACEBO_COMPARATOR | Placebo Comparator to be administered to healthy participants. |
| Name | Type | Description |
|---|---|---|
| XmAb412 Monoclonal Bispecific Antibody | DRUG | Monoclonal Bispecific Antibody |
| Placebo | DRUG | Placebo |
Inclusion Criteria: * Age 18-55 years old * Must be in good health with no significant medical history * BMI 18-35 kg/m2 * Contraceptive use consistent with local regulations * Able and willing to provide written informed consent Exclusion Criteria: * Any physical condition that prohibits study c...